Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction OVLY Q3 2023 Earnings EPS of 089 Reported Amidst Flat Market Reaction GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology MaxLinear Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty FSV Q1 2026 Earnings EPS Surpasses Estimates by Over 6 MNST Q1 2026 Earnings EPS Beats Estimates by 83 Stock Edges Higher